FDA Drug recall D-0531-2023
Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each Syringe supplied in individually labeled pol…
- FDA Drug
- Class III
- terminated
- Published 2023-04-19
On 2023-04-19 the FDA classified a Class III recall of Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each Syringe supplied in individually labeled pol… by Pine Pharmaceuticals, citing labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0531-2023 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2023-03-27 |
| Published | 2023-04-19 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Pine Pharmaceuticals |
| Distribution | US |
Product
Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each Syringe supplied in individually labeled poly envelopes (primary packaging). Repackaged by Pine Pharmaceuticals, Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150, Office Use Only, Not for Resale. Secondary packaging consists of a coated cardboard box, with order-specific label indicating lot number housed within order/container. NDC # 69194-0458-1
Reason
Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect.
Identifiers
| code_info | Lot # 66377, Exp. Date: 06/28/2023. Syringe may be labeled incorrectly as lot# 66316 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0531-2023%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.